Literature DB >> 29309509

Time-varying proportional odds model for mega-analysis of clustered event times.

Tanya P Garcia1, Karen Marder2, Yuanjia Wang3.   

Abstract

Mega-analysis, or the meta-analysis of individual data, enables pooling and comparing multiple studies to enhance estimation and power. A challenge in mega-analysis is estimating the distribution for clustered, potentially censored event times where the dependency structure can introduce bias if ignored. We propose a new proportional odds model with unknown, time-varying coefficients, and random effects. The model directly captures event dependencies, handles censoring using pseudo-values, and permits a simple estimation by transforming the model into an easily estimable additive logistic mixed effect model. Our method consistently estimates the distribution for clustered event times even under covariate-dependent censoring. Applied to three observational studies of Huntington's disease, our method provides, for the first time in the literature, evidence of similar conclusions about motor and cognitive impairments in all studies despite different recruitment criteria.

Entities:  

Mesh:

Year:  2019        PMID: 29309509      PMCID: PMC6402758          DOI: 10.1093/biostatistics/kxx065

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  13 in total

1.  Low-rank scale-invariant tensor product smooths for generalized additive mixed models.

Authors:  Simon N Wood
Journal:  Biometrics       Date:  2006-12       Impact factor: 2.571

Review 2.  CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches.

Authors:  Douglas R Langbehn; Michael R Hayden; Jane S Paulsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-03-05       Impact factor: 3.568

3.  Penalised regression splines: theory and application to medical research.

Authors:  Giampiero Marra; Rosalba Radice
Journal:  Stat Methods Med Res       Date:  2008-09-24       Impact factor: 3.021

4.  At risk for Huntington disease: The PHAROS (Prospective Huntington At Risk Observational Study) cohort enrolled.

Authors: 
Journal:  Arch Neurol       Date:  2006-07

5.  Marginal models for clustered time-to-event data with competing risks using pseudovalues.

Authors:  Brent R Logan; Mei-Jie Zhang; John P Klein
Journal:  Biometrics       Date:  2011-03       Impact factor: 2.571

6.  Interrater agreement in the assessment of motor manifestations of Huntington's disease.

Authors:  Penelope Hogarth; Elise Kayson; Karl Kieburtz; Karen Marder; David Oakes; Diana Rosas; Ira Shoulson; Nancy S Wexler; Anne B Young; Hongwei Zhao
Journal:  Mov Disord       Date:  2005-03       Impact factor: 10.338

7.  Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group.

Authors: 
Journal:  Mov Disord       Date:  1996-03       Impact factor: 10.338

8.  Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Authors:  Sarah J Tabrizi; Rachael I Scahill; Gail Owen; Alexandra Durr; Blair R Leavitt; Raymund A Roos; Beth Borowsky; Bernhard Landwehrmeyer; Chris Frost; Hans Johnson; David Craufurd; Ralf Reilmann; Julie C Stout; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2013-05-09       Impact factor: 44.182

9.  Characterization of a large group of individuals with huntington disease and their relatives enrolled in the COHORT study.

Authors:  E Ray Dorsey
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

10.  Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study.

Authors:  Jane S Paulsen; Jeffrey D Long; Hans J Johnson; Elizabeth H Aylward; Christopher A Ross; Janet K Williams; Martha A Nance; Cheryl J Erwin; Holly J Westervelt; Deborah L Harrington; H Jeremy Bockholt; Ying Zhang; Elizabeth A McCusker; Edmond M Chiu; Peter K Panegyres
Journal:  Front Aging Neurosci       Date:  2014-04-22       Impact factor: 5.750

View more
  2 in total

1.  Individual participant data meta-analysis with mixed-effects transformation models.

Authors:  Bálint Tamási; Michael Crowther; Milo Alan Puhan; Ewout W Steyerberg; Torsten Hothorn
Journal:  Biostatistics       Date:  2022-10-14       Impact factor: 5.279

2.  Disease Progression in Huntington Disease: An Analysis of Multiple Longitudinal Outcomes.

Authors:  Tanya P Garcia; Yuanjia Wang; Ira Shoulson; Jane S Paulsen; Karen Marder
Journal:  J Huntingtons Dis       Date:  2018
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.